Freund John Gordon
Insider CIK 1296771 · XNPT Director · COLL Director, 10% owner · PRTO Director, 10% owner · CNCE Director, 10% owner · TTPH Director, 10% owner · STRO Director, 10% owner · DRNA 10% owner · MAKO Director · ACRX 10% owner · SIBN Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SIBN SI-BONE, Inc. | A Award | 2026-06-04 | 2026-06-08 | 10,957 | — | $0 | 54,258 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | S Sale | 2026-05-18 | 2026-05-20 | 20 | $34.05 | $681 | 83,952 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | M Exercise deriv | 2026-05-15 | 2026-05-18 | 8,700 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | M Exercise | 2026-05-15 | 2026-05-18 | 8,700 | $16.49 | $143.5K | 88,099 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | S Sale | 2026-05-15 | 2026-05-18 | 4,127 | $34.54 | $142.5K | 83,972 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2026-05-14 | 2026-05-18 | 8,741 | — | $0 | 79,399 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2025-08-08 | 2025-08-11 | 12,132 | $15.99 | $194.0K | 91,767 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | S Sale | 2025-08-08 | 2025-08-12 | 11,659 | $34.36 | $400.6K | 23,129 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | M Exercise deriv | 2025-06-09 | 2025-06-11 | 15,000 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | S Sale | 2025-06-09 | 2025-06-11 | 6,601 | $30.62 | $202.1K | 70,658 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | M Exercise | 2025-06-09 | 2025-06-11 | 15,000 | $13.45 | $201.8K | 77,259 | SEC↗ |
| SIBN SI-BONE, Inc. | A Award | 2025-06-05 | 2025-06-06 | 8,675 | — | $0 | 43,301 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2025-05-15 | 2025-05-19 | 9,791 | — | $0 | 62,259 | SEC↗ |
| SIBN SI-BONE, Inc. | A Award | 2024-06-26 | 2024-06-27 | 8,791 | — | $0 | 34,626 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2024-06-06 | 2024-06-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2024-05-16 | 2024-05-16 | 7,693 | — | $0 | 52,468 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2023-08-09 | 2023-08-11 | 30,000 | $20.54 | $616.2K | 103,899 | SEC↗ |
| SIBN SI-BONE, Inc. | A Award | 2023-06-09 | 2023-06-13 | 4,866 | — | $0 | 25,835 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2023-05-18 | 2023-05-19 | 9,792 | — | $0 | 44,775 | SEC↗ |
| SIBN SI-BONE, Inc. | A Award | 2022-06-16 | 2022-06-21 | 8,324 | — | $0 | 20,969 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2022-06-06 | 2022-06-08 | 18,500 | — | $0 | 18,500 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2022-05-19 | 2022-05-23 | 14,035 | — | $0 | 34,983 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-06-16 | 2021-06-16 | 12,591 | $31.41 | $395.5K | 331,366 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-06-15 | 2021-06-16 | 21,511 | $31.11 | $669.2K | 343,957 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-06-14 | 2021-06-16 | 17,990 | $31.28 | $562.7K | 365,468 | SEC↗ |
| SIBN SI-BONE, Inc. | A Award | 2021-06-10 | 2021-06-14 | 3,848 | — | $0 | 12,645 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2021-06-03 | 2021-06-07 | 18,500 | — | $0 | 18,500 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-05-28 | 2021-06-01 | 45,220 | $30.06 | $1.36M | 383,458 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-05-27 | 2021-06-01 | 26,367 | $30.93 | $815.5K | 428,678 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-05-26 | 2021-05-26 | 17,138 | $31.85 | $545.8K | 455,045 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-05-25 | 2021-05-26 | 1,696 | $32.55 | $55.2K | 472,183 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-05-24 | 2021-05-26 | 200 | $32.76 | $6.6K | 473,879 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-05-24 | 2021-05-26 | 50,827 | $32.54 | $1.65M | 474,079 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2021-05-20 | 2021-05-24 | 9,941 | — | $0 | 20,948 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-03-17 | 2021-03-18 | 600,000 | $30.25 | $18.15M | 524,906 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-03-17 | 2021-03-18 | 66,200 | $31.63 | $2.09M | 1,124,906 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-03-16 | 2021-03-18 | 55,053 | $30.33 | $1.67M | 1,191,106 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-03-15 | 2021-03-15 | 80,887 | $30.90 | $2.50M | 1,246,159 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-03-12 | 2021-03-15 | 91,072 | $31.39 | $2.86M | 1,327,046 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2021-03-11 | 2021-03-15 | 63,928 | $31.05 | $1.98M | 1,418,118 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | J Other | 2020-12-10 | 2020-12-14 | 56,327 | — | $0 | 56,327 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | J Other | 2020-12-10 | 2020-12-14 | 118,735 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2020-12-03 | 2020-12-04 | 47,886 | $23.39 | $1.12M | 1,482,046 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2020-12-02 | 2020-12-04 | 100,000 | $23.28 | $2.33M | 1,529,932 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | J Other | 2020-11-09 | 2020-11-12 | 118,735 | — | $0 | 118,735 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | J Other | 2020-11-09 | 2020-11-12 | 560,053 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2020-10-19 | 2020-10-20 | 190,053 | $22.00 | $4.18M | 2,129,932 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | S Sale | 2020-09-18 | 2020-09-22 | 400,000 | $12.00 | $4.80M | 560,053 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | S Sale | 2020-09-11 | 2020-09-15 | 500,000 | $10.00 | $5.00M | 960,053 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | S Sale | 2020-08-19 | 2020-08-21 | 500,000 | $8.72 | $4.36M | 1,460,053 | SEC↗ |
| SIBN SI-BONE, Inc. | A Award | 2020-06-16 | 2020-06-18 | 8,797 | — | $0 | 8,797 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2020-06-05 | 2020-06-08 | 12,000 | — | $0 | 12,000 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2020-05-20 | 2020-05-22 | 8,095 | — | $0 | 8,095 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2020-05-20 | 2020-05-22 | 4,047 | — | $0 | 11,007 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2020-01-27 | 2020-08-14 | 1,000,000 | $21.50 | $21.50M | 2,819,985 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2019-12-10 | 2019-12-12 | 524 | $2.19 | $1.1K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2019-12-10 | 2019-12-12 | 14,507 | $2.19 | $31.8K | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2019-12-02 | 2019-12-04 | 574,916 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2019-12-02 | 2019-12-04 | 8,625 | — | $0 | 8,625 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2019-11-12 | 2019-11-14 | 575,000 | — | $0 | 574,916 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2019-11-12 | 2019-11-14 | 8,423 | — | $0 | 34,788 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2019-11-08 | 2019-11-12 | 700 | — | $0 | 354 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2019-11-08 | 2019-11-12 | 703,588 | $0.99 | $696.6K | 2,175,882 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-26 | 2019-08-27 | 152,424 | $18.40 | $2.80M | 3,819,985 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-23 | 2019-08-23 | 180 | $20.03 | $3.6K | 3,972,409 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-22 | 2019-08-23 | 2,185 | $20.05 | $43.8K | 3,972,589 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-21 | 2019-08-23 | 18,144 | $20.17 | $366.0K | 3,974,774 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-21 | 2019-08-23 | 27,067 | $20.14 | $545.1K | 3,992,918 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale | 2019-08-12 | 2019-08-14 | 400,000 | $18.25 | $7.30M | 4,019,985 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2019-06-17 | 2019-06-19 | 11,610 | — | $0 | 11,610 | SEC↗ |
| SIBN SI-BONE, Inc. | A Award deriv | 2019-06-13 | 2019-06-17 | 15,741 | — | $0 | 15,741 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-06-10 | 2019-06-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2019-04-25 | 2019-04-29 | 9,414 | — | $0 | 9,414 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2019-04-25 | 2019-04-29 | 4,707 | — | $0 | 6,960 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2018-11-14 | 2018-11-16 | 5,859 | — | $0 | 26,365 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2018-11-14 | 2018-11-16 | 400,000 | — | $0 | 1,149,916 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 652,347 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 792,195 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 398,676 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | X Exercise deriv | 2018-10-19 | 2018-10-19 | 39,421 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | X Exercise deriv | 2018-10-19 | 2018-10-19 | 39,421 | — | $0 | 816,099 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale deriv | 2018-10-19 | 2018-10-19 | 23,904 | $15.00 | $358.6K | 792,195 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 2,213,425 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | X Exercise deriv | 2018-10-19 | 2018-10-19 | 39,421 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | X Exercise deriv | 2018-10-19 | 2018-10-19 | 39,421 | — | $0 | 816,099 | SEC↗ |
| SIBN SI-BONE, Inc. | S Sale deriv | 2018-10-19 | 2018-10-19 | 23,904 | $14.00 | $334.7K | 792,195 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 2,213,425 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 792,195 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 652,347 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 398,676 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 2,213,425 | — | $0 | 2,213,425 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 690,689 | — | $0 | 3,696,309 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 398,676 | — | $0 | 4,094,985 | SEC↗ |
| SIBN SI-BONE, Inc. | P Buy | 2018-10-19 | 2018-10-19 | 325,000 | $15.00 | $4.88M | 4,419,985 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 792,195 | — | $0 | 3,005,620 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 792,195 | — | $0 | 3,005,620 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 2,213,425 | — | $0 | 2,213,425 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 690,689 | — | $0 | 3,696,309 | SEC↗ |
| SIBN SI-BONE, Inc. | P Buy | 2018-10-19 | 2018-10-19 | 325,000 | $15.00 | $4.88M | 4,419,985 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 398,676 | — | $0 | 4,094,985 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 18,698,578 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 12,846,023 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 25,015,635 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 514,211 | — | $0 | 1,960,053 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 520,264 | — | $0 | 1,445,842 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 925,578 | — | $0 | 925,578 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | A Award deriv | 2018-09-26 | 2018-09-27 | 26,033 | — | $0 | 26,033 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2018-06-08 | 2018-06-11 | 12,700 | — | $0 | 12,700 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-05-30 | 2018-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2018-05-24 | 2018-05-29 | 4,506 | — | $0 | 4,506 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2018-05-24 | 2018-05-29 | 2,253 | — | $0 | 2,253 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2018-03-19 | 2018-03-21 | 600,000 | — | $0 | 1,549,916 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2018-03-19 | 2018-03-21 | 8,791 | — | $0 | 20,506 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2017-12-05 | 2017-12-07 | 11,715 | — | $0 | 11,715 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | J Other | 2017-12-05 | 2017-12-07 | 800,000 | — | $0 | 2,149,916 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy deriv | 2017-06-22 | 2017-06-26 | 1,054 | $1000.00 | $1.05M | 1,054 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2017-06-20 | 2017-06-21 | 6,666 | — | $0 | 6,666 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-05-31 | 2017-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2017-05-24 | 2017-05-25 | 19,853 | — | $0 | 19,853 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 5,000 | $7.03 | $35.1K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | D To issuer deriv | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 488,560 | $7.03 | $3.43M | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 15,000 | $7.03 | $105.5K | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 3,899 | $7.03 | $27.4K | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 27 | $7.03 | $190 | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 21,200 | $7.03 | $149.0K | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 3,645 | $7.03 | $25.6K | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 22,633 | $7.03 | $159.1K | 0 | SEC↗ |
| XNPT XENOPORT INC | U Tender | 2016-07-05 | 2016-07-06 | 3,080 | $7.03 | $21.7K | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2016-06-09 | 2016-06-13 | 8,700 | — | $0 | 8,700 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2016-06-09 | 2016-06-14 | 6,666 | — | $0 | 6,666 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2016-06-08 | 2016-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2016-05-17 | 2016-05-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2016-05-17 | 2016-05-19 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2016-05-17 | 2016-05-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2016-05-17 | 2016-05-19 | 5,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | S Sale | 2015-11-11 | 2015-11-13 | 909 | $6.68 | $6.1K | 488,560 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2015-09-10 | 2015-09-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2015-06-10 | 2015-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2015-06-02 | 2015-06-03 | 6,666 | — | $0 | 6,666 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2015-05-19 | 2015-05-21 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2015-05-19 | 2015-05-21 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2015-05-19 | 2015-05-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2015-05-19 | 2015-05-21 | 5,000 | — | $0 | 13,899 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-13 | 10,714,286 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-13 | 5,881,724 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-13 | 2,638,030 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-13 | 1,552,795 | — | $0 | 1,552,795 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-13 | 864,798 | — | $0 | 2,799,916 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | P Buy | 2015-05-12 | 2015-05-13 | 150,000 | $12.00 | $1.80M | 2,949,916 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-13 | 382,323 | — | $0 | 1,935,118 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2015-05-11 | 2015-05-13 | 4,493 | — | $0 | 4,493 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2015-05-11 | 2015-05-13 | 4,493 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2015-05-11 | 2015-05-13 | 3,006 | — | $0 | 6,012 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2015-05-11 | 2015-05-13 | 300,000 | — | $0 | 590,146 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2015-02-20 | 2015-02-24 | 37,532 | $26.02 | $976.6K | 1,719,671 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,341,664 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise deriv | 2014-10-27 | 2014-10-29 | 121,760 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 3,932,747 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,436,437 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 5,000,000 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2014-10-27 | 2014-10-29 | 1,389,064 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,173,913 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,173,913 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,341,664 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 5,000,000 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,436,437 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 3,932,747 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2014-10-27 | 2014-10-29 | 1,389,064 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise deriv | 2014-10-27 | 2014-10-29 | 121,760 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | S Sale | 2014-10-27 | 2014-10-29 | 56,038 | $10.00 | $560.4K | 1,432,930 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise | 2014-10-27 | 2014-10-29 | 121,760 | $4.60 | $560.1K | 1,488,968 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-29 | 200,000 | $10.00 | $2.00M | 200,000 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 1,167,208 | — | $0 | 1,367,208 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-29 | 200,000 | $10.00 | $2.00M | 200,000 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 1,167,208 | — | $0 | 1,367,208 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise | 2014-10-27 | 2014-10-29 | 121,760 | $4.60 | $560.1K | 1,488,968 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | S Sale | 2014-10-27 | 2014-10-29 | 56,038 | $10.00 | $560.4K | 1,432,930 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-10-02 | 2014-10-03 | 27,726 | $20.72 | $574.5K | 968,008 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-10-02 | 2014-10-03 | 77,862 | $21.02 | $1.64M | 890,146 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 14,400 | $20.41 | $293.9K | 1,123,480 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 127,746 | $20.89 | $2.67M | 995,734 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-30 | 2014-10-01 | 56,618 | $20.17 | $1.14M | 1,137,880 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-29 | 2014-10-01 | 95,648 | $20.19 | $1.93M | 1,194,498 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-17 | 2014-09-18 | 77,000 | $17.36 | $1.34M | 1,290,146 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-16 | 2014-09-18 | 67,356 | $17.03 | $1.15M | 1,367,146 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-12 | 2014-09-15 | 53,544 | $17.01 | $910.8K | 1,434,502 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-11 | 2014-09-15 | 2,100 | $17.00 | $35.7K | 1,488,046 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-08 | 2014-09-09 | 4,473 | $15.01 | $67.1K | 1,490,146 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-05 | 2014-09-09 | 12,227 | $15.01 | $183.5K | 1,494,619 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-04 | 2014-09-05 | 41,200 | $15.06 | $620.5K | 1,506,846 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-09-03 | 2014-09-05 | 142,100 | $15.04 | $2.14M | 1,548,046 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-06-23 | 2014-06-25 | 47,184 | $13.77 | $649.7K | 1,690,146 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-06-20 | 2014-06-23 | 82,716 | $13.65 | $1.13M | 1,737,330 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2014-06-19 | 2014-06-23 | 70,100 | $13.08 | $916.9K | 1,820,046 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2014-06-17 | 2014-06-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2014-06-12 | 2014-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2014-06-11 | 2014-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | P Buy | 2014-06-03 | 2014-06-04 | 12,500 | $3.93 | $49.1K | 22,633 | SEC↗ |
| XNPT XENOPORT INC | P Buy | 2014-05-23 | 2014-05-27 | 9,500 | $3.72 | $35.3K | 21,200 | SEC↗ |
| XNPT XENOPORT INC | P Buy | 2014-05-22 | 2014-05-27 | 5,500 | $3.75 | $20.6K | 11,700 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2014-05-14 | 2014-05-27 | 5,000 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2014-05-14 | 2014-05-16 | 3,006 | — | $0 | 3,006 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2014-05-14 | 2014-05-16 | 4,493 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2014-05-14 | 2014-05-27 | 5,000 | — | $0 | 8,899 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2014-03-12 | 2014-03-14 | 300,000 | — | $0 | 1,890,146 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2014-03-12 | 2014-03-14 | 4,493 | — | $0 | 4,493 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2014-03-07 | 2014-03-11 | 1,300,000 | — | $0 | 2,871,933 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-20 | 2014-02-21 | 2,200,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-20 | 2014-02-21 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-20 | 2014-02-21 | 600,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-20 | 2014-02-21 | 530,974 | — | $0 | 952,726 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-20 | 2014-02-21 | 106,194 | — | $0 | 1,058,920 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-20 | 2014-02-21 | 150,000 | $14.00 | $2.10M | 1,208,920 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-20 | 2014-02-21 | 389,380 | — | $0 | 421,752 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 179,322 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 312,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 21,697 | — | $0 | 21,697 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 1,043,429 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 21,697 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 755 | — | $0 | 755 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-05 | 200,000 | $15.00 | $3.00M | 1,734,751 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 312,000 | — | $0 | 312,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 1,043,429 | — | $0 | 1,534,751 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 179,322 | — | $0 | 491,322 | SEC↗ |
| MAKO MAKO Surgical Corp. | D To issuer deriv | 2013-12-17 | 2013-12-17 | 143,157 | $23.80 | $3.41M | 0 | SEC↗ |
| MAKO MAKO Surgical Corp. | D To issuer deriv | 2013-12-17 | 2013-12-17 | 487,450 | $22.56 | $11.00M | 0 | SEC↗ |
| MAKO MAKO Surgical Corp. | D To issuer deriv | 2013-12-17 | 2013-12-17 | 17,317 | $18.36 | $317.9K | 0 | SEC↗ |
| MAKO MAKO Surgical Corp. | D To issuer deriv | 2013-12-17 | 2013-12-17 | 3,338 | $4.54 | $15.2K | 0 | SEC↗ |
| MAKO MAKO Surgical Corp. | D To issuer deriv | 2013-12-17 | 2013-12-17 | 3,300 | $2.93 | $9.7K | 0 | SEC↗ |
| MAKO MAKO Surgical Corp. | D To issuer deriv | 2013-12-17 | 2013-12-17 | 3,300 | $17.13 | $56.5K | 0 | SEC↗ |
| MAKO MAKO Surgical Corp. | D To issuer | 2013-12-17 | 2013-12-17 | 20,000 | $30.00 | $600.0K | 0 | SEC↗ |
| MAKO MAKO Surgical Corp. | D To issuer | 2013-12-17 | 2013-12-17 | 22,702 | $30.00 | $681.1K | 0 | SEC↗ |
| MAKO MAKO Surgical Corp. | D To issuer | 2013-12-17 | 2013-12-17 | 2,245,249 | $30.00 | $67.36M | 0 | SEC↗ |
| MAKO MAKO Surgical Corp. | A Award deriv | 2013-06-04 | 2013-06-05 | 17,317 | — | $0 | 17,317 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2013-05-16 | 2013-05-16 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2013-05-16 | 2013-05-16 | 5,000 | — | $0 | 8,899 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2013-05-14 | 2013-05-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2013-05-14 | 2013-05-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,726,086 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,090,000 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 27,226,760 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2013-03-25 | 2013-03-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 11,422,045 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 72,069 | — | $0 | 82,414 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2013-03-25 | 2013-03-27 | 681,012 | $7.00 | $4.77M | 2,190,146 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 393,864 | — | $0 | 570,281 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 94,003 | — | $0 | 176,417 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 938,853 | — | $0 | 1,509,134 | SEC↗ |
| MAKO MAKO Surgical Corp. | A Award deriv | 2012-06-11 | 2012-06-12 | 3,338 | — | $0 | 3,338 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 256,228 | $0.13 | $33.3K | 256,228 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 284,698 | $3.40 | $968.0K | 4,161,933 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2012-05-16 | 2012-05-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2012-05-16 | 2012-05-17 | 5,000 | — | $0 | 5,000 | SEC↗ |